the future of clinical trials
Triall is working hard to create an ecosystem to tackle some of the persistent issues currently felt by the clinical trial industry using targeted integrations with blockchain.
Triall is laying the groundwork for tomorrow’s digital playing field in medical research and clinical trials.
Sphereon is proud to be helping develop an infrastructure of blockchain-integrated microservices, facilitating safe and efficient data exchanges between medical research professionals and their many isolated software systems.
Verial eTMF: an electronic Trial Master File solution
Read More
Verial TMFTriall’s first software solution Verial eTMF is a blockchain-integrated document management solution that supports clinical research professionals in building and managing their electronic Trial Master File (eTMF).
Uniquely, Verial eTMF enables users to generate verifiable proof of the integrity of their clinical trial data by utilizing the Factom Protocol’s blockchain infrastructure.
Verial eTMF is in production and currently being onboarded by 6 commercial clinical trial projects across 3 countries, involving an approximate total of 2500 participants. More projects are lined up.
How does Triall work?
The clinical trial software market is rapidly growing due to the digitalization and globalization of clinical research. Many industry stakeholders are currently switching from general solutions to advanced, dedicated applications. So how does Triall fit in this picture?
Currently, Triall is building the world’s first blockchain-enabled clinical research ecosystem that provides software solutions and APIs for all industry professionals involved in clinical trials. Triall aims to use the advantages of blockchain technology to truly add value, by promoting trust, research data integrity, auditability, and system interoperability. Their initiative is geared towards solving many persistent problems that make medical innovation complex, lengthy, and resource inefficient.
Triall envisions the world’s first online environment that is inclusive to all types of clinical research professionals—regardless of function, budget, or organizational type. From first-time PhD researchers to experienced industry professionals, from pharmacist to research nurse, Triall is committed to optimizing and simplifying clinical operations for all.
Their online environment is managed by the non-profit Triall Foundation, which is responsible for the development, management, and maintenance of the ecosystem and its functionalities. This foundation hopes to reinvest any future excess income in the clinical community through incubator and charity schemes.
Next to providing off-the-shelf solutions that meet industry needs, Triall aims to create an environment in which novel initiatives from the community are supported and facilitated to thrive. This makes Triall function as a true clinical trial ecosystem, and, at the same time, enables them to provide solutions tailored to the specific needs of the clinical research community.
Triall solutions are currently integrated with the Factom protocol, an open-source data integrity protocol that is fully optimized for enterprise adoption and has a track-record of industrial and governmental applications. Integrating with Factom has provided Triall with network strength and security right from the start.
Cooperation is key
As we say so often, cooperation is key. Triall is not just building a product, but an eco-system with all stakeholders in clinical trials. Sphereon is proud to partner with Triall and Dizer Capital to help.
Triall is laying the groundwork for tomorrow’s digital playing field in medical research and clinical trials. They are developing an infrastructure of blockchain-integrated microservices, facilitating safe and efficient data exchanges between medical research professionals and their many isolated software systems. Gradually, the’re building the world’s first online, multi-sided platform for clinical trials.
https://insights.triall.io/building-the-triall-ecosystem/
Dizer Capital is a private equity firm founded by Yassin Mobarak and focused on startups in the technology sector, particularly in the areas of focus are DLT/Blockchain, clean energy, ehealth and financial inclusion.